CASPIAN Proves Too Choppy For AZ Imfinzi/Tremelimumab Combo

But Imfinzi Benefit Reinforced For Small Cell Lung Cancer

Baku_City
CASPIAN not so serene for tremelimumab • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D